Mortality Outcomes in Patients With Plaque Psoriasis and Hidradenitis Suppurativa: The Role of Biologic Therapy
Both psoriasis (pso) and hidradenitis suppurativa (hs) are associated with an increased risk of mortality, which appears to be mitigated by biologic therapy. Early and comprehensive management of these conditions, including systemic inflammation control and comorbidity screening, may improve survival outcomes.
Authors
- Beatriz Joven (ORCID: https://orcid.org/0000-0003-1140-7618)
- Raquel Rivera (ORCID: https://orcid.org/0000-0002-4604-0724)
- Alfonso Gotor‐Rivera (ORCID: https://orcid.org/0009-0005-9063-8554)
Institutions
- Universidad Complutense de Madrid (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Hospital Universitario 12 De Octubre (ES)
Publication Details
- Journal
- Actas Dermo-Sifiliográficas
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1016/j.ad.2025.104525
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00